Cicero Inc (CICN) 0.0198 $CICN Nexidia and Cicero

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Red Banyan: A Powerhouse in B2B Support Red Banyan isn't just any player in the communications game; it's carved out a reputation as the go-to when businesses hit rough waters. You see, for the third consecutive year, this Fort Lauderdale-based firm bagged the Inc. Power Partner Award—a nod to its clout in the B2B arena. This accolade ain't about fancy ads; it's about...

REA Group's Bold Step into the UK Real Estate Market REA Group Ltd, a subsidiary of News Corporation, is stirring things up in the real estate sector with its recent proposal to acquire Rightmove plc, one of the UK's top real estate portals. This non-binding offer shows REA Group's ambitions to grow beyond Australia and tap into new international markets. Plans for...

SiriusXM Announces Quarterly Cash Dividend SiriusXM (NASDAQ: SIRI) recently shared an important update with its shareholders. The Board of Directors has declared a quarterly cash dividend amounting to $0.27 per share of common stock. This significant step reflects the company’s ongoing commitment to providing value to its investors. Dividend Payment Details Stockholders...

Indonesia Stock Market: Daily Overview Trading on the Indonesian stock exchange finished a touch lower, with the IDX Composite Index slipping 0.06%. Losses in Infrastructure, Agriculture, and Basic Industry set the tone, and modest gains elsewhere weren’t enough to change the direction. It was a cautious, choppy session that underlined a still-challenging backdrop. Key...

Revolutionary Ice Clearing Tool for Vehicles In the winter months, battling ice and snow on car windows can be a frustrating experience for many drivers. Recognizing this challenge, an inventive mind has come up with a solution that promises to change the way we deal with this common problem. The new design, known as the ICE SCRAPER, has been developed to enhance the...